​Invest Hong Kong (InvestHK) and Hong Kong Economic and Trade Office (Tokyo) jointly organised an Innovation and Technology (Biotech) Mission, comprising 15 delegates from 10 Japanese biotechnology companies, two Japanese venture capital firms and a Japanese startup incubator to visit Hong Kong from May 15 to 18 to understand Hong Kong's innovation and technology (I&T) market and its investment environment.
This is the second sectoral business mission from Japan in recent years, following a food and beverage mission successfully held in April 2023.
The mission delegates joined the Asia Summit on Global Health organised by the Hong Kong Trade Development Council on May 16 and 17, and attended the deal-making session to conduct a number of business matching meetings with potential investors, investees and business partners.
At the welcome dinner held on May 16, the Associate Director-General of Investment Promotion, Dr Jimmy Chiang, said, "Hong Kong's strengths in scientific research, policy support, intellectual property protection, financial markets, and talent make the city an ideal place for life and health sciences development. We look forward to assisting more Mainland and foreign I&T companies to set up their base in Hong Kong,"
On May 17, the delegates visited the Hong Kong Science and Technology Parks Corporation (HKSTP) to attend a briefing session on the business environment and opportunities available in Hong Kong and a tour to the HKSTP's Japanese tenants’ lab and other facilities. The delegates then attended a networking dinner organised by InvestHK.
Follow this news feed: East Asia